MetLife Investment Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Buy |
56,844
+8,048
| +16% | +$76.6K | ﹤0.01% | 1641 |
|
|
2025
Q1 | $510K | Sell |
48,796
-671
| -1% | -$7.02K | ﹤0.01% | 1714 |
|
|
2024
Q4 | $1.17M | Buy |
49,467
+2,748
| +6% | +$64.7K | 0.01% | 1333 |
|
|
2024
Q3 | $1.68M | Hold |
46,719
| – | – | 0.01% | 1116 |
|
|
2024
Q2 | $1.65M | Buy |
46,719
+16,237
| +53% | +$573K | 0.01% | 1069 |
|
|
2024
Q1 | $865K | Buy |
30,482
+7,549
| +33% | +$214K | 0.01% | 1378 |
|
|
2023
Q4 | $305K | Hold |
22,933
| – | – | ﹤0.01% | 1986 |
|
|
2023
Q3 | $205K | Hold |
22,933
| – | – | ﹤0.01% | 2191 |
|
|
2023
Q2 | $258K | Buy |
22,933
+3,167
| +16% | +$35.6K | ﹤0.01% | 2119 |
|
|
2023
Q1 | $228K | Hold |
19,766
| – | – | ﹤0.01% | 2138 |
|
|
2022
Q4 | $229K | Hold |
19,766
| – | – | ﹤0.01% | 2164 |
|
|
2022
Q3 | $251K | Hold |
19,766
| – | – | ﹤0.01% | 2140 |
|
|
2022
Q2 | $136K | Hold |
19,766
| – | – | ﹤0.01% | 2555 |
|
|
2022
Q1 | $191K | Buy |
19,766
+7,180
| +57% | +$69.2K | ﹤0.01% | 2380 |
|
|
2021
Q4 | $150K | Hold |
12,586
| – | – | ﹤0.01% | 2236 |
|
|
2021
Q3 | $204K | Hold |
12,586
| – | – | ﹤0.01% | 2092 |
|
|
2021
Q2 | $265K | Buy |
+12,586
| New | +$265K | ﹤0.01% | 1976 |
|
|
2021
Q1 | – | Sell |
-7,479
| Closed | -$157K | – | 2321 |
|
|
2020
Q4 | $157K | Buy |
+7,479
| New | +$157K | ﹤0.01% | 2108 |
|